Trial intelligence / Profile preview

Intranasal Ketamine for Acute Pain in the Emergency Department

NCT03233035Phase 2Completed

Sponsor
Université de Monastir
Start
Jan 2018
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ketamine in acute pain, sponsored by Université de Monastir. Started Jan 2018; status: completed.

02

Drugs

ketamine
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT03233035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03233035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call